DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1ADZENYS ER
02 1ADZENYS XR-ODT
03 1ASACOL
04 1BUDESONIDE
05 2BUPROPION HYDROCHLORIDE
06 1COTEMPLA XR-ODT
07 1DICLOFENAC SODIUM
08 1DIMETHYL FUMARATE
09 2DIVALPROEX SODIUM
10 1ENTOCORT EC
11 4ESOMEPRAZOLE MAGNESIUM
12 1ESOMEPRAZOLE STRONTIUM
13 1FENOFIBRIC ACID
14 2HABITROL
15 1LAMOTRIGINE
16 1LANSOPRAZOLE
17 2NEXIUM
18 1NIFEDIPINE
19 1OMEPRAZOLE
20 2OXYBUTYNIN CHLORIDE
21 1PANTOPRAZOLE SODIUM
22 2PRILOSEC
23 1TAMSULOSIN HYDROCHLORIDE
24 1TIZANIDINE HYDROCHLORIDE
25 1VIMOVO
01 119651
02 119810
03 220076
04 121153
05 121324
06 121957
07 122056
08 122511
09 175281
10 175289
11 175876
12 176745
13 177100
14 177285
15 178225
16 178279
17 190210
18 190797
19 1201567
20 1201791
21 1202332
22 1202342
23 1202366
24 1202784
25 1203636
26 1204325
27 1204326
28 1205489
29 1206296
30 1207367
31 1208705
32 1209605
33 1210305
01 31No
02 3Yes
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Drug : HABITROL
Dosage Form : Film, Extended Release; Transdermal
Application Number : 20076
Country : US
Patented : No
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Drug : ESOMEPRAZOLE MAGNESIUM
Dosage Form : CAPSULE, DELAYED REL PELLETS; ORAL
Application Number : 78279
Country : US
Patented : No
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Drug : HABITROL
Dosage Form : FILM, EXTENDED RELEASE; TRANSDERMAL
Application Number : 20076
Country : US
Patented : No
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Drug : OMEPRAZOLE
Dosage Form : CAPSULE, DELAYED REL PELLETS; ORAL
Application Number : 75876
Country : US
Patented : No
Drug : ASACOL
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 19651
Country : US
Patented : No
Drug : PRILOSEC
Dosage Form : FOR SUSPENSION, DELAYED RELEASE; ORAL
Application Number : 22056
Country : US
Patented : No
Drug : DIVALPROEX SODIUM
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 90210
Country : US
Patented : No
Drug : BUDESONIDE
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 207367
Country : US
Patented : No
Drug : DIVALPROEX SODIUM
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 77100
Country : US
Patented : No
Drug : LAMOTRIGINE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 201791
Country : US
Patented : No
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LOOKING FOR A SUPPLIER?
